Analyst Consensus ?
ConsensusBuy27 ratings
Bullish1970.4%
Neutral829.6%
Bearish00.0%
FN2 Earnings Intelligence
Zebra Technologies Corporation (ZBRA) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 8, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Truist Securities | Hold | Hold | Maintain | Oct 5, 2026 |
| Needham | Buy | Buy | Maintain | Sep 15, 2026 |
| TD Cowen | Buy | Buy | Maintain | Aug 5, 2026 |
| Keybanc | Overweight | Overweight | Maintain | Aug 5, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Aug 5, 2026 |
| BNP Paribas | Outperform | Outperform | Maintain | Aug 5, 2026 |
| Barclays | Overweight | Overweight | Maintain | Aug 5, 2026 |
| Baird | Outperform | Outperform | Maintain | May 13, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Aug 6, 2025 |
| UBS | Buy | Buy | Maintain | Apr 30, 2025 |
| Stephens & Co. | Overweight | Overweight | Maintain | Aug 2, 2024 |
| Exane BNP Paribas | Neutral | Underperform | Upgrade | Jun 13, 2024 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Apr 8, 2024 |
| Credit Suisse | Outperform | Outperform | Maintain | Aug 2, 2023 |
| JP Morgan | Overweight | Neutral | Upgrade | Apr 4, 2022 |
| Northcoast Research | Buy | Neutral | Upgrade | Mar 23, 2021 |
| Imperial Capital | Outperform | Outperform | Maintain | Nov 20, 2019 |
| Atlantic Equities | Overweight | Overweight | Maintain | Aug 27, 2019 |
| Berenberg | Buy | Buy | Maintain | Mar 7, 2019 |
| Wells Fargo | Market Perform | Market Perform | Maintain | Feb 27, 2018 |
| Wellington Shields | Buy | Hold | Upgrade | Nov 8, 2017 |
| CLSA | Buy | Buy | Maintain | Aug 3, 2016 |
| Goldman Sachs | Neutral | Neutral | Maintain | Jun 8, 2016 |
| Avondale Partners | Perform | Market Perform | Maintain | Mar 28, 2016 |
| Oppenheimer | Outperform | Outperform | Maintain | Jan 20, 2016 |
| Barrington Research | Outperform | Outperform | Maintain | Aug 26, 2015 |
| Sidoti & Co. | Neutral | Buy | Downgrade | Jan 28, 2013 |
Upside is calculated against the persisted current price $384.8. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Truist Financial | Jamie Cook | $378 | $374.64 | -1.8% | Oct 5, 2026 |
| Needham | Robert Jamieson | $435 | $351.81 | +13.0% | Sep 15, 2026 |
| Truist Financial | Analyst unavailable | $355 | $373.87 | -7.7% | Aug 5, 2026 |
| Morgan Stanley | Meta Marshall | $360 | $373.76 | -6.4% | Aug 5, 2026 |
| KeyBanc | Analyst unavailable | $430 | $368.83 | +11.7% | Aug 5, 2026 |
| Barclays | Analyst unavailable | $410 | $368.83 | +6.5% | Aug 5, 2026 |
| Wolfe Research | Analyst unavailable | $317 | $271 | -17.6% | Jul 9, 2026 |
| Truist Financial | Analyst unavailable | $296 | $267.85 | -23.1% | Jul 2, 2026 |
| Barclays | Analyst unavailable | $346 | $245.69 | -10.1% | Jun 23, 2026 |
| Barclays | Guy Hardwick | $345 | $241.79 | -10.3% | May 13, 2026 |
| KeyBanc | Analyst unavailable | $305 | $241.79 | -20.7% | May 13, 2026 |
| Robert W. Baird | Analyst unavailable | $310 | $241.79 | -19.4% | May 13, 2026 |
| Truist Financial | Jamie Cook | $256 | $236.14 | -33.5% | Apr 20, 2026 |
| UBS | Damian Karas | $335 | $268.88 | -12.9% | Feb 13, 2026 |
| Barclays | Analyst unavailable | $330 | $274.15 | -14.2% | Feb 13, 2026 |
| Morgan Stanley | Meta Marshall | $323 | $274.15 | -16.1% | Feb 12, 2026 |
| Barclays | Guy Hardwick | $351 | $241.08 | -8.8% | Feb 6, 2026 |
| Barclays | Guy Hardwick | $368 | $259.48 | -4.4% | Jan 12, 2026 |
| Truist Financial | Jamie Cook | $291 | $254.22 | -24.4% | Dec 18, 2025 |
| Truist Financial | Analyst unavailable | $331 | $275.96 | -14.0% | Oct 29, 2025 |
| Barclays | Analyst unavailable | $360 | $274.31 | -6.4% | Oct 29, 2025 |
| Truist Financial | Analyst unavailable | $350 | $296.64 | -9.0% | Oct 8, 2025 |
| Barclays | Analyst unavailable | $375 | $296.64 | -2.5% | Oct 7, 2025 |
| Barclays | Tim Long | $301 | $302.6 | -21.8% | Aug 5, 2025 |
| UBS | Damian Karas | $425 | $318.36 | +10.4% | Feb 18, 2025 |
| Robert W. Baird | Analyst unavailable | $380 | $331.08 | -1.2% | Feb 18, 2025 |
| Truist Financial | Jamie Cook | $383 | $384.68 | -0.5% | Oct 29, 2024 |
| Robert W. Baird | Richard Eastman | $375 | $348.12 | -2.5% | Jul 31, 2024 |
| Truist Financial | Jamie Cook | $345 | $348.12 | -10.3% | Jul 31, 2024 |
| BNP Paribas | Andrew Buscaglia | $305 | $304.56 | -20.7% | Jun 13, 2024 |
| Needham | James Ricchiuti | $370 | $323.87 | -3.8% | May 16, 2024 |
| Robert W. Baird | Richard Eastman | $330 | $314.56 | -14.2% | May 1, 2024 |
| Stephens | Tommy Moll | $380 | $314.56 | -1.2% | May 1, 2024 |
| Wolfe Research | Brad Hewitt | $337 | $290.38 | -12.4% | Apr 8, 2024 |
| Truist Financial | Jamie Cook | $300 | $284.5 | -22.0% | Mar 13, 2024 |
| Needham | James Ricchiuti | $255 | $196.82 | -33.7% | Nov 1, 2023 |
| Morgan Stanley | Analyst unavailable | $260 | $270.82 | -32.4% | Dec 13, 2022 |
| Credit Suisse | Analyst unavailable | $319 | $258.1 | -17.1% | Dec 13, 2022 |
| UBS | Analyst unavailable | $495 | $325.44 | +28.6% | Aug 4, 2022 |
| Stephens | Analyst unavailable | $500 | $323.32 | +29.9% | Aug 3, 2022 |
| Needham | Analyst unavailable | $450 | $323.32 | +16.9% | Aug 3, 2022 |
| Needham | Analyst unavailable | $500 | $368.14 | +29.9% | May 4, 2022 |
| Morgan Stanley | Meta Marshall | $400 | $393.68 | +4.0% | Apr 16, 2022 |
| Wolfe Research | Brian Lau | $469 | $437.18 | +21.9% | Mar 20, 2022 |
| Needham | James Ricchiuti | $535 | $388.79 | +39.0% | Mar 10, 2022 |
Track every rating change on ZBRA the moment it posts. Free to start.
Start freeOne email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.